Alvotech (ALVO) Cash & Equivalents (2020 - 2026)

Alvotech's Cash & Equivalents history runs 7 years deep, the most recent figure standing at $63.8 million for Q1 2026.

• Quarterly Cash & Equivalents rose 24.12% year-over-year to $63.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $63.8 million (up 24.12% YoY) and the FY2025 annual result came in at $172.4 million, up 235.15% from the prior year.
• Cash & Equivalents was $63.8 million for Q1 2026 at Alvotech, down from $172.4 million in the prior quarter.
• Across five years, Cash & Equivalents topped out at $172.4 million in Q4 2025 and bottomed at $10.9 million in Q2 2024.
• A 5-year average of $79.9 million and a median of $64.3 million in 2024 frame the typical range for Cash & Equivalents.
• Annual changes were most pronounced in 2023 — Cash & Equivalents slumped 83.2% — and 2025, when it surged 1283.88%.
• Alvotech's Cash & Equivalents stood at $66.4 million in 2022, then plunged by 83.2% to $11.2 million in 2023, then jumped by 360.95% to $51.4 million in 2024, then surged by 235.15% to $172.4 million in 2025, then tumbled by 62.97% to $63.8 million in 2026.
• Business Quant data shows ALVO's Cash & Equivalents at $63.8 million in Q1 2026, $172.4 million in Q4 2025, and $51.4 million in Q3 2025.